Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.
Omicron: South Korea Developed ‘molecular Diagnosis’ to Detect Covid Variant in 20 Minutes On December 13th, 2021; As Omicron Covid-19 strains continue to spread, South Korean researchers developed a ...
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...
Zacks Investment Research on MSN
OraSure files for FDA review of molecular self-test & Colli-Pee device
OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at ...
CRISPR gene editing and next-generation sequencing (NGS) have transformed clinical and life sciences research. CRISPR permits the selective targeting and editing of specific nucleotide sequences, with ...
DUBLIN--(BUSINESS WIRE)--The "Polymerase Chain Reaction (PCR) Technologies and Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. PCR is a powerful molecular biology ...
American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as a diagnostic marker, a key ...
LONDON--(BUSINESS WIRE)--The POC molecular diagnostics market is poised to grow by USD 1.31 billion during 2020-2024 progressing at a CAGR of over 14% during the forecast period. Technavio suggests ...
Global molecular diagnostics market size was worth USD 22.32 bn in 2022 and is estimated to grow to USD 39.42 bn by 2030, with a CAGR of approximately 7.37%. PUNE ...
The "In Situ Hybridization Market Report by Product, Technique, Application, End User, Countries and Company Analysis ...
Labroots is excited to announce our 13th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2025 held on May 14th, 2025! The Precision Medicine: Genomics, ...
KIFFIK Biomedical Closes Oversubscribed Series A to Advance Real-Time Molecular Diagnostics Platform
MIAMI, FL / ACCESS Newswire / December 17, 2025 / KIFFIK Biomedical announced today the successful close of its Series A financing, completed ahead of schedule and significantly oversubscribed. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results